The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Hypersensitivity and Loss of Disease Site Targeting Caused by Antibody Responses to PEGylated Liposomes
Open accessAbstract
The systemic application of nucleic acid drugs requires delivery systems that overcome the poor pharmacokinetics, limited biodistribution, and inefficient uptake of nucleic acids. PEGylated liposomes show considerable promise because of their intrinsic ability to accumulate at disease sites and facilitate transfection of target cells. Unlike many viral vectors, PEGylated liposomes are generally considered to be nonimmunogenic. We have developed a PEGylated liposome for the systemic administration of plasmid DNA that achieves high levels of selective gene expression at distal tumor sites. Here we report that the in vivo efficacy and safety of these systems can be severely compromised following repeat administration. This phenomenon is characterized by a loss of disease site targeting, accelerated clearance from the blood, and acute hypersensitivity. These effects are fully attributable to a surprisingly robust, long-lived antibody response generated against polyethylene glycol (PEG) that results from the strong adjuvant effect of the plasmid payload. Importantly, immunogenicity may be substantially reduced by modifying the alkyl chain of the PEG-lipid conjugate, thereby allowing successful repeat dosing of the modified plasmid formulations without adverse side effects. Immunogenicity is a relevant concern for a number of nonviral delivery systems given the potent immunostimulatory properties of many nucleic acid drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,573
Pharmacokinetics of Pegylated Liposomal Doxorubicin: Review of Animal and Human Studies
Gabizon, A., Shmeeda, H., & Barenholz, Y. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342050-00002 · Cited by 1,634
Papahadjopoulos, D., Allen, T. M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S. K., Lee, K. D., Woodle, M. C., Lasic, D. D., & Redemann, C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11460 · Cited by 1,620
Allen, T. M., Hansen, C., Martin, F., Redemann, C., & Yau-Young, A. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90246-5 · Cited by 1,391
TLR9 signals after translocating from the ER to CpG DNA in the lysosome
Latz, E., Schoenemeyer, A., Visintin, A., Fitzgerald, K. A., Monks, B. G., Knetter, C. F., Lien, E., Nilsen, N. J., Espevik, T., & Golenbock, D. T. (2004) · Nature Immunology · doi:10.1038/ni1028 · Cited by 1,361
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
Judge, A. D., Sood, V., Shaw, J. R., Fang, D., McClintock, K., & MacLachlan, I. (2005) · Nature Biotechnology · doi:10.1038/nbt1081 · Cited by 1,250
Self-citationHornung, V., Guenthner-Biller, M., Bourquin, C., Ablasser, A., Schlee, M., Uematsu, S., Noronha, A., Manoharan, M., Akira, S., de Fougerolles, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1191 · Cited by 1,232
Roy, K., Mao, H.-Q., Huang, S. K., & Leong, K. W. (1999) · Nature Medicine · doi:10.1038/7385 · Cited by 1,106
Jego, G., Palucka, A. K., Blanck, J.-P., Chalouni, C., Pascual, V., & Banchereau, J. (2003) · Immunity · doi:10.1016/s1074-7613(03)00208-5 · Cited by 1,067
Immunotherapeutic uses of CpG oligodeoxynucleotides
Klinman, D. M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1329 · Cited by 1,012
Liposomes as immunological adjuvants
ALLISON, A. C., & GREGORIADIS, G. (1974) · Nature · doi:10.1038/252252a0 · Cited by 675
Dams, E. T. M., Laverman, P., Oyen, W. J. G., Storm, G., Scherphof, G. L., van der Meer, J. W. M., Corstens, F. H. M., & Boerman, O. C. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35391-1 · Cited by 607
Harrington, K. J., Mohammadtaghi, S., Uster, P. S., Glass, D. M., Peters, A. M., Vile, R. G., & Stewart, J. S. W. (2001) · PubMed · Cited by 575
Uziely, B., Jeffers, S., Isacson, R., Kutsch, K., Wei-Tsao, D., Yehoshua, Z., Libson, E., Muggia, F. M., & Gabizon, A. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.7.1777 · Cited by 477
Sioud, M. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.03.013 · Cited by 418
B lymphocytes express and lose syndecan at specific stages of differentiation.
Sanderson, R. D., Lalor, P., & Bernfield, M. (1989) · Cell Regulation · doi:10.1091/mbc.1.1.27 · Cited by 406
Interleukin 15 Controls both Proliferation and Survival of a Subset of Memory-Phenotype CD8+ T Cells
Judge, A. D., Zhang, X., Fujii, H., Surh, C. D., & Sprent, J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020772 · Cited by 331
Self-citationAccelerated clearance of PEGylated liposomes in rats after repeated injections
Ishida, T., Maeda, R., Ichihara, M., Irimura, K., & Kiwada, H. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00462-5 · Cited by 327
Pathways of anaphylaxis in the mouse
Strait, R. T., Morris, S. C., Yang, M., Qu, X.-W., & Finkelman, F. D. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.123302 · Cited by 312
A Scalable, Extrusion-Free Method for Efficient Liposomal Encapsulation of Plasmid DNA
Jeffs, L. B., Palmer, L. R., Ambegia, E. G., Giesbrecht, C., Ewanick, S., & MacLachlan, I. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-1873-z · Cited by 307
Self-citationPoeck, H., Wagner, M., Battiany, J., Rothenfusser, S., Wellisch, D., Hornung, V., Jahrsdorfer, B., Giese, T., Endres, S., & Hartmann, G. (2004) · Blood · doi:10.1182/blood-2003-08-2972 · Cited by 303
Laverman, P., Carstens, M. G., Boerman, O. C., Th. M. Dams, E., Oyen, W. J. G., van Rooijen, N., Corstens, F. H. M., & Storm, G. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29419-2 · Cited by 298
Richter, A. W., & Åkerblom, E. (1983) · International Archives of Allergy and Immunology · doi:10.1159/000233309 · Cited by 282
Richter, A. W., & Åkerblom, E. (1984) · International Archives of Allergy and Immunology · doi:10.1159/000233512 · Cited by 229
Thymus-independent antigens: complexity of B-lymphocyte activation revealed
Mosier, D. E., & Subbarao, B. (1982) · Immunology Today · doi:10.1016/0167-5699(82)90095-0 · Cited by 219
Szebeni, J., Baranyi, L., Savay, S., Milosevits, J., Bunger, R., Laverman, P., Metselaar, J. M., Storm, G., Chanan-Khan, A., Liebes, L., et al. (2002) · Journal of Liposome Research · doi:10.1081/lpr-120004790 · Cited by 212
Semple, S. C., Harasym, T. O., Clow, K. A., Ansell, S. M., Klimuk, S. K., & Hope, M. J. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078113 · Cited by 211
Signaling in B cells via Toll-like receptors
Peng, S. L. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.03.003 · Cited by 209
Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes
Harding, J. A., Engbers, C. M., Newman, M. S., Goldstein, N. I., & Zalipsky, S. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00056-4 · Cited by 202
Ambegia, E., Ansell, S., Cullis, P., Heyes, J., Palmer, L., & MacLachlan, I. (2005) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2005.02.001 · Cited by 202
Self-citationAccelerated clearance of a second injection of PEGylated liposomes in mice
Ishida, T., Masuda, K., Ichikawa, T., Ichihara, M., Irimura, K., & Kiwada, H. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00085-1 · Cited by 183
Gursel, I., Gursel, M., Ishii, K. J., & Klinman, D. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3324 · Cited by 182
Webb, M. S., Saxon, D., Wong, F. M. P., Lim, H. J., Wang, Z., Bally, M. B., Choi, L. S. L., Cullis, P. R., & Mayer, L. D. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00077-7 · Cited by 171
Szebeni, J., Baranyi, L., Savay, S., Bodo, M., Morse, D. S., Basta, M., Stahl, G. L., Bünger, R., & Alving, C. R. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.3.h1319 · Cited by 171
Accelerated Clearance of Polyethylene Glycol-Modified Proteins by Anti-Polyethylene Glycol IgM
Cheng, T., Wu, P.-Y., Wu, M., Chern, J., & Roffler, S. R. (1999) · Bioconjugate Chemistry · doi:10.1021/bc980143z · Cited by 147
Biological stability of [3H]cholesteryl oleyl ether in cultured fibroblasts and intact rat
Stein, Y., Halperin, G., & Stein, O. T. (1980) · FEBS Letters · doi:10.1016/0014-5793(80)80771-x · Cited by 87
Liposomally targeted cytotoxic drugs for the treatment of cancer
Harrington, K. J., Syrigos, K. N., & Vile, R. G. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357002243 · Cited by 64
Tc-99m-PEG-Liposomes for the Evaluation of Colitis in Crohn's Disease
Brouwers, A. H., Jong, D. D., Dams, E. T. M., Oyen, W. J. G., Boerman, O. C., Laverman, P., Naber, A. H. J., Storm, G., & Corstens, F. H. M. (2000) · Journal of drug targeting · doi:10.3109/10611860008997901 · Cited by 54
Boeckler, C., Dautel, D., Schelté, P., Frisch, B., Wachsmann, D., Klein, J.-P., & Schuber, F. J. (1999) · European Journal of Immunology · Cited by 53
Li, W. M., Bally, M. B., & Schutze-Redelmeier, M.-P. M. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00277-8 · Cited by 53
Phillips, N. C., & Dahman, J. (1995) · Immunology Letters · doi:10.1016/0165-2478(94)00251-l · Cited by 51
Interaction of anti-cholesterol antibodies with human lipoproteins
Dijkstra, J., Swartz, G. M., Raney, J. J., Aniagolu, J. U., Toro, L. A., Nacy, C. A., & Green, S. J. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.2006 · Cited by 40
Li, W. M., Mayer, L. D., & Bally, M. B. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.976 · Cited by 37
Progress towards a synthetic virus for systemic gene therapy.
MacLachlan, I., Cullis, P. R., & Graham, R. W. (1999) · PubMed · Cited by 32
Self-citation
Cited by
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
The current landscape of nucleic acid therapeutics
Kulkarni, J. A., Witzigmann, D., Thomson, S. B., Chen, S., Leavitt, B. R., Cullis, P. R., & van der Meel, R. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00898-0 · Cited by 1,371
Polyethylene glycol (PEG): A versatile polymer for pharmaceutical applications
D’souza, A. A., & Shegokar, R. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1182485 · Cited by 1,282
The role of lipid components in lipid nanoparticles for vaccines and gene therapy
Hald Albertsen, C., Kulkarni, J. A., Witzigmann, D., Lind, M., Petersson, K., & Simonsen, J. B. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114416 · Cited by 1,185
Ernsting, M. J., Murakami, M., Roy, A., & Li, S.-D. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.013 · Cited by 1,012
Metadata
- Authors
- Judge, A., McClintock, K., Phelps, J. R., & MacLachlan, I.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2006-02
- Volume
- 13
- Issue
- 2
- Pages
- 328-337
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W1990622580
- Cited by
- 280
- References
- 47
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.